Skip to main content

Table 1 Demographics and disease characteristics in 20 patients with active SLE who were started on Belimumab

From: Real life experience on the effect of Belimumab in patients with active systemic lupus

Mean age 36+/- 9.2
Gender Female 20
Time diagnosis 1- year 6pts
1-5 years 11pts
6-10 years 3 pts
Clinical findings 9 Pts joint and constitutional symptoms
7 Pts skin and constitutional symptoms
3 Pts joint and hematologic symptoms
Ethnicity Caucasian 20pts